Literature DB >> 9650854

Inhibition of nociceptin on sensory neuropeptide release and mast cell-mediated plasma extravasation in rats.

J Németh1, Z Helyes, G Oroszi, M Thán, E Pintér, J Szolcsányi.   

Abstract

Nociceptin (20 microg/kg i.p.) strongly inhibited cutaneous Evans blue accumulation in the chronically denervated hindpaw of the rat in response to mast cell degranulating peptide (MCDP, 0.25 microg in 100 microl) but it had no and marginal effect on plasma extravasation induced by 5-hydroxytryptamine (5-HT, 0.5 microg in 100 microl) and histamine (0.1 microg in 100 microl), respectively. Release of sensory neuropeptides such as substance P, calcitonin gene-related peptide (CGRP) and somatostatin from the rat isolated trachea in response to capsaicin (10(-8) M) or bradykinin (10(-7) M) were also attenuated by nociceptin (100 and 300 nM). It is concluded that chemically induced discharge of mediators from mast cells and from capsaicin-sensitive afferent nerve terminals are both inhibited by nociceptin that participates in the anti-inflammatory effect of the peptide.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9650854     DOI: 10.1016/s0014-2999(98)00216-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice.

Authors:  Derek Vang; Jinny A Paul; Julia Nguyen; Huy Tran; Lucile Vincent; Dennis Yasuda; Nurulain T Zaveri; Kalpna Gupta
Journal:  Haematologica       Date:  2015-08-20       Impact factor: 9.941

2.  Effects of nociceptin and nocistatin on antidromic vasodilatation in hairless skin of the rat hindlimb in vivo.

Authors:  H Häbler; L Timmermann; J Stegmann; W Jänig
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 3.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  Anti-inflammatory effect of synthetic somatostatin analogues in the rat.

Authors:  Z Helyes; E Pintér; J Németh; G Kéri; M Thán; G Oroszi; A Horváth; J Szolcsányi
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

5.  Stimulation of sensory neuropeptide release by nociceptin/orphanin FQ leads to hyperaemia in acutely inflamed rat knees.

Authors:  Chunfen Zhang; Jason J McDougall
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

6.  Nociceptin/orphanin FQ inhibits capsaicin-induced guinea-pig airway contraction through an inward-rectifier potassium channel.

Authors:  Yanlin Jia; Xin Wang; Sonia I Aponte; Maria A Rivelli; Richard Yang; Charles A Rizzo; Michel R Corboz; Tony Priestley; John A Hey
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

7.  Nociceptin inhibits vanilloid TRPV-1-mediated neurosensitization induced by fenoterol in human isolated bronchi.

Authors:  Christophe Faisy; Emmanuel Naline; Céline Rouget; Paul-André Risse; Emmanuel Guerot; Jean-Yves Fagon; Thierry Chinet; Nicolas Roche; Charles Advenier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-04       Impact factor: 3.000

8.  Nociceptin inhibits airway microvascular leakage induced by HCl intra-oesophageal instillation.

Authors:  Céline Rouget; Yong Yao Cui; Bruno D'Agostino; Christophe Faisy; Emmanuel Naline; Marc Bardou; Charles Advenier
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

Review 9.  Nociceptin system as a target in sepsis?

Authors:  Róisín Thomas; Cordula Stover; David G Lambert; Jonathan P Thompson
Journal:  J Anesth       Date:  2014-04-12       Impact factor: 2.078

10.  Receptor mediation and nociceptin inhibition of bradykinin-induced plasma extravasation in the knee joint of the rat.

Authors:  Kumi Moriyama; Jia Liu; Yeon Jang; Yun Jeong Chae; Yan Wang; James Mitchell; Stefan Grond; Xiaokang Han; Yilei Xing; Guo-xi Xie; Pamela Pierce Palmer
Journal:  Inflamm Res       Date:  2009-06-21       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.